|
||
J. Exp. Med.,
Volume 186, Number 11, December 1, 1997 1885-1896
By




From the * Division of International Medicine and Infectious Disease and Among the major antimicrobial products of macrophages are reactive intermediates of the oxidation of nitrogen (RNI) and the reduction of oxygen (ROI). Selection of recombinants in
acidified nitrite led to the cloning of a novel gene, noxR1, from a pathogenic clinical isolate of
Mycobacterium tuberculosis. Expression of noxR1 conferred upon Escherichia coli and Mycobacterium
smegmatis enhanced ability to resist RNI and ROI, whether the bacteria were exposed to exogenous compounds in medium or to endogenous products in macrophages. These studies provide the first identification of an RNI resistance mechanism in mycobacteria, point to a new mechanism for resistance to ROI, and raise the possibility that inhibition of the noxR1 pathway
might enhance the ability of macrophages to control tuberculosis.
Division of
Hematology-Oncology, Department of Medicine, Cornell University Medical College,
New York 10021
This article has been cited by other articles:
| TABLE OF CONTENTS |
|